caBozantinib in cOllectiNg ductS Renal Cell cArcInoma

NCT03354884 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Collecting Duct Carcinoma (Kidney)

Interventions

DRUG: cabozantinib

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano